Congrats to the Top Picks 2019, Mid-Year
Congratulations to our Top Picks for 2019! We’re halfway through the year, and the markets are doing great—and so are our Top Picks! The Dow Jones Industrial Average has gained 11.8%; the S&P 500 is up 14.3%, the...
Read More
This utility has just received approval to acquire three wind farms in Missouri and Kansas.
Read More
Seven analysts have raised their EPS estimates for this tech company in the past 30 days.
Read More
This Indian solar power company saw its revenues rise by 22% in its second quarter.
Read More
This oil company is expected to grow at an annual rate of 30% over the next five years.
Read More
This Mexican chemical company and plastic tubing company recently announced a call for a special shareholder’s meeting on a proposed $150 million extraordinary dividend.
Read More
Sell this Iron Ore Company
Read More
Today’s pick is a leader in recycling systems for the food retail industry in Europe and the U.S.
Read More
Four analysts have raised their earnings estimates for this global beverage company, forecasting 23% annual growth over the next five years. The shares have a current dividend yield of 3.62%, paid twice yearly.
Read More
After beating the market handily in 2017, our Wall Street's Best experts are back with their top stock picks for 2018. Here are five of them.
Read More
These two banks are a great entrée into participating in the ADR markets.
Read More
This 5-star-rated fund has a current dividend yield of 6.5%, paid monthly.
Read More
This infrastructure firm has shown—in recent moves—that it looks after its shareholders. The fund has a current dividend yield of 8.74%, paid quarterly.
Read More
This stock looks attractive, as defense spending is expected to rise. The shares have a current dividend yield of 3.61%, paid annually.
Read More
The CEO of this global insurer recently remarked that the company was interested in ‘big takeovers’ in the U.S. This stock is a play on rising rates.
Allianz SE (AZSEY)
From Global Investing
Allianz SE (AZSEY) has taken its time recovering from the walkout of Bill which...
Read More
Sell: ½ of Benitec Biopharma (BNTC 2)
From Global Investing
Updated from Investment Digest 771, July 22, 2015
We will sell half of our Benitech common, taking a 42% loss on my lamentable Australian pick, despite its patented tech winning a clear green light from the billionaire...
Read More
This medical device company, while not yet making a profit, is forecast for double-digit growth this year and next. It is also rated ‘Buy’ by Zacks and three other brokerage companies.
Mazor Robotics (MZOR) From Global Investing
Mazor Robotics (MZOR), the Israeli maker of spine brain...
Read More
It’s certainly been an interesting six months! The hope of better economic growth at the beginning of the year—heightened by December’s rate hike—sank with bottoming energy prices and renewed fears of recession, knocking more than 200 points of the stock markets by February. steady—albeit...
Read More
This drug maker is growing at double-digit rates, forecasted to expand almost 29% this quarter and 20% in the following three months.
Novo Nordisk A/S (NVO) From Global Investing
Novo Nordisk A/S (NVO) was formed by the merger of two Danish firms specializing in making for...
Read More
Analysts are forecasting 50% growth for this Canadian pipeline company. The shares have a current dividend yield of 9.57%, paid monthly.
Veresen (VSN.TO) From Global Investing
Veresen (VSN.TO), the Canadian gas pipeline and storage company, was hit hard shortly after I recommended the stock for service...
Read More
Call Financial Freedom Federation Customer Service at
(800) 777-2658
